Pathstone Holdings’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,940
Closed -$52.9K 2390
2024
Q3
$52.9K Buy
+10,940
New +$52.9K ﹤0.01% 2273